Drug Profile
Leptospirosis vaccine trivalent - Finlay Institute
Alternative Names: vax-SPIRALLatest Information Update: 17 Nov 2014
Price :
$50
*
At a glance
- Originator Finlay Institute of Cuba
- Developer Finlay Vaccine Institute
- Class Bacterial vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Leptospirosis
Most Recent Events
- 12 Nov 2014 Launched for Leptospirosis (Prevention) in Cuba (IM)